These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 1766675)

  • 1. erg, an ets-related gene, codes for sequence-specific transcriptional activators.
    Reddy ES; Rao VN
    Oncogene; 1991 Dec; 6(12):2285-9. PubMed ID: 1766675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Fli-1 proto-oncogene, involved in erythroleukemia and Ewing's sarcoma, encodes a transcriptional activator with DNA-binding specificities distinct from other Ets family members.
    Zhang L; Lemarchandel V; Romeo PH; Ben-David Y; Greer P; Bernstein A
    Oncogene; 1993 Jun; 8(6):1621-30. PubMed ID: 8502483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An inhibitory carboxyl-terminal domain in Ets-1 and Ets-2 mediates differential binding of ETS family factors to promoter sequences of the mb-1 gene.
    Hagman J; Grosschedl R
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):8889-93. PubMed ID: 1409581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of the ets genes and their products.
    Watson DK; Ascione R; Papas TS
    Crit Rev Oncog; 1990; 1(4):409-36. PubMed ID: 1964597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human ERG-2 protein is a phosphorylated DNA-binding protein--a distinct member of the ets family.
    Murakami K; Mavrothalassitis G; Bhat NK; Fisher RJ; Papas TS
    Oncogene; 1993 Jun; 8(6):1559-66. PubMed ID: 8502479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New human erg isoforms generated by alternative splicing are transcriptional activators.
    Duterque-Coquillaud M; Niel C; Plaza S; Stehelin D
    Oncogene; 1993 Jul; 8(7):1865-73. PubMed ID: 8510931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered expression of Erg and Ets-2 transcription factors is associated with genetic changes at 21q22.2-22.3 in immortal and cervical carcinoma cell lines.
    Simpson S; Woodworth CD; DiPaolo JA
    Oncogene; 1997 May; 14(18):2149-57. PubMed ID: 9174050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sea urchin erg homolog defines a highly conserved erg-specific domain.
    Qi S; Chen ZQ; Papas TS; Lautenberger JA
    DNA Seq; 1992; 3(2):127-9. PubMed ID: 1457815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ets oncogene family.
    Dhulipal PD
    Indian J Exp Biol; 1997 Apr; 35(4):315-22. PubMed ID: 9315229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA binding by c-Ets-1, but not v-Ets, is repressed by an intramolecular mechanism.
    Lim F; Kraut N; Framptom J; Graf T
    EMBO J; 1992 Feb; 11(2):643-52. PubMed ID: 1311254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro.
    Kovar H; Aryee DN; Jug G; Henöckl C; Schemper M; Delattre O; Thomas G; Gadner H
    Cell Growth Differ; 1996 Apr; 7(4):429-37. PubMed ID: 9052984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ets-related protein Elk-1 is homologous to the c-fos regulatory factor p62TCF.
    Hipskind RA; Rao VN; Mueller CG; Reddy ES; Nordheim A
    Nature; 1991 Dec 19-26; 354(6354):531-4. PubMed ID: 1722028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentially spliced erg-3 product functions as a transcriptional activator.
    Prasad DD; Rao VN; Lee L; Reddy ES
    Oncogene; 1994 Feb; 9(2):669-73. PubMed ID: 8290279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the DNA-binding and transcriptional activation functions of human Fli-1 protein.
    Rao VN; Ohno T; Prasad DD; Bhattacharya G; Reddy ES
    Oncogene; 1993 Aug; 8(8):2167-73. PubMed ID: 8336942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG.
    Sorensen PH; Lessnick SL; Lopez-Terrada D; Liu XF; Triche TJ; Denny CT
    Nat Genet; 1994 Feb; 6(2):146-51. PubMed ID: 8162068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure, expression and alternative splicing of the human c-ets-1 proto-oncogene.
    Reddy ES; Rao VN
    Oncogene Res; 1988; 3(3):239-46. PubMed ID: 3060801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A residue of the ETS domain mutated in the v-ets oncogene is essential for the DNA-binding and transactivating properties of the ETS-1 and ETS-2 proteins.
    Soudant N; Albagli O; Dhordain P; Flourens A; Stéhelin D; Leprince D
    Nucleic Acids Res; 1994 Sep; 22(19):3871-9. PubMed ID: 7937106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myb and Ets transcription factors cooperate at the myb-inducible promoter of the tom-1 gene.
    Burk O; Klempnauer KH
    Biochim Biophys Acta; 1999 Sep; 1446(3):243-52. PubMed ID: 10524199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the expression and function of the transcription factor PU.1 (Spi-1 proto-oncogene) between murine macrophages and B lymphocytes.
    Ross IL; Dunn TL; Yue X; Roy S; Barnett CJ; Hume DA
    Oncogene; 1994 Jan; 9(1):121-32. PubMed ID: 8302571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the DNA binding and transcriptional activation domains of the erg protein.
    Siddique HR; Rao VN; Lee L; Reddy ES
    Oncogene; 1993 Jul; 8(7):1751-5. PubMed ID: 8510921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.